Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.

Victor MorenoMaria-Pilar Barretina-GinestaJesús García-DonasGordon C JaysonPatricia RoxburghRaúl Márquez VázquezAgnieszka MichaelAntonio Antón-TorresRichard BrownDavid KrigeBrian Champion Iain A McNeish

Published in: Journal for immunotherapy of cancer (2022)

NCT02028117.

Keyphrases

clinical trial
phase ii
open label
study protocol
double blind
randomized controlled trial
chemotherapy induced